HK1225968A1
(en )
2017-09-22
Combination therapy for treatment of hbv infections
IL259783A
(en )
2018-07-31
Methods of treatment of malignancies
PT3212233T
(en )
2020-07-16
Combination therapy for treatment of disease
FI3851537T3
(en )
2024-03-21
Treatment of hyperbilirubinemia
HUE053654T2
(en )
2021-07-28
Combinations of fgfr- and cmet-inhibitors for the treatment of cancer
HK1215864A1
(en )
2016-09-23
Cannula for catgut-embedding therapy
HK1210788A1
(en )
2016-05-06
Therapeutic biologic for treatment of hepatocellular carcinoma
HK1232220A1
(en )
2018-01-05
Derivatives of 5-benzylisoquinoline for the treatment of cardiovascular diseases 5-
PT3151814T
(en )
2019-11-05
Treatment of a skin lesion
GB201416832D0
(en )
2014-11-05
Methods of treatment
PL3129483T3
(en )
2019-05-31
Combination therapy for the treatment of autoimmune diseases
IL249502B
(en )
2020-09-30
Novel therapeutic uses of benzylideneguanidine derivatives for the treatment of proteopathies
IL250576A0
(en )
2017-03-30
Therapeutic multi-peptides t specific immune therapy for treatment of brain metastasis
GB201409363D0
(en )
2014-07-09
Skin cancer treatment
GB201408297D0
(en )
2014-06-25
Treatment of cancer
GB201412010D0
(en )
2014-08-20
Treatment of hypertransaminasemia
IL258228A
(en )
2018-05-31
Combination therapy regimen for treatment of hcv
GB201417456D0
(en )
2014-11-19
Treatment of cancer
ZA201408372B
(en )
2015-11-25
Therapeutic biologic for treatment of hepatocellular carcinoma
GB201613350D0
(en )
2016-09-14
Treatment of hyperpigmentation
GB201513922D0
(en )
2015-09-23
Treatment of hyperpigmentation
GB201506944D0
(en )
2015-06-10
Therapeutic treatment
GB201523018D0
(en )
2016-02-10
The traditional chinese medicine combination for the treatment of prostate
PT3851537T
(en )
2024-03-06
Treatment of hyperbilirubinemia
GB201409362D0
(en )
2014-07-09
Treatment of cancer